ID   PCKGC_HUMAN             Reviewed;         622 AA.
AC   P35558; A8K437; B4DT64; Q8TCA3; Q9UJD2;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 3.
DT   10-MAY-2017, entry version 183.
DE   RecName: Full=Phosphoenolpyruvate carboxykinase, cytosolic [GTP];
DE            Short=PEPCK-C;
DE            EC=4.1.1.32;
GN   Name=PCK1 {ECO:0000312|HGNC:HGNC:8724}; Synonyms=PEPCK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS LEU-184 AND
RP   ASP-586.
RX   PubMed=8490617; DOI=10.1093/hmg/2.1.1;
RA   Stoffel M., Xiang K.S., Espinosa R. III, Cox N.J., le Beau M.M.,
RA   Bell G.I.;
RT   "cDNA sequence and localization of polymorphic human cytosolic
RT   phosphoenolpyruvate carboxykinase gene (PCK1) to chromosome 20, band
RT   q13.31: PCK1 is not tightly linked to maturity-onset diabetes of the
RT   young.";
RL   Hum. Mol. Genet. 2:1-4(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT LEU-184.
RC   TISSUE=Liver;
RX   PubMed=8325643; DOI=10.1006/geno.1993.1250;
RA   Ting C.-N., Burgess D.L., Chamberlain J.S., Keith T.P., Falls K.,
RA   Meisler M.H.;
RT   "Phosphoenolpyruvate carboxykinase (GTP): characterization of the
RT   human PCK1 gene and localization distal to MODY on chromosome 20.";
RL   Genomics 16:698-706(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS GLN-55; THR-60;
RP   ILE-138; VAL-267; LYS-276; ILE-368 AND SER-427.
RG   NIEHS SNPs program;
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   LEU-184.
RC   TISSUE=Kidney, and Pericardium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT LEU-184.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   LEU-184 AND VAL-267.
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-74.
RX   PubMed=8547315; DOI=10.1016/0167-4781(95)00194-8;
RA   O'Brien R.M., Printz R.L., Halmi N., Tiesinga J.J., Granner D.K.;
RT   "Structural and functional analysis of the human phosphoenolpyruvate
RT   carboxykinase gene promoter.";
RL   Biochim. Biophys. Acta 1264:284-288(1995).
RN   [9]
RP   INDUCTION.
RX   PubMed=1656199;
RA   Liu J., Hanson R.W.;
RT   "Regulation of phosphoenolpyruvate carboxykinase (GTP) gene
RT   transcription.";
RL   Mol. Cell. Biochem. 104:89-100(1991).
RN   [10]
RP   ACETYLATION AT LYS-70; LYS-71 AND LYS-594, ENZYME REGULATION,
RP   MUTAGENESIS OF LYS-70; LYS-71 AND LYS-594, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=20167786; DOI=10.1126/science.1179689;
RA   Zhao S., Xu W., Jiang W., Yu W., Lin Y., Zhang T., Yao J., Zhou L.,
RA   Zeng Y., Li H., Li Y., Shi J., An W., Hancock S.M., He F., Qin L.,
RA   Chin J., Yang P., Chen X., Lei Q., Xiong Y., Guan K.L.;
RT   "Regulation of cellular metabolism by protein lysine acetylation.";
RL   Science 327:1000-1004(2010).
RN   [11]
RP   ACETYLATION AT LYS-70; LYS-71 AND LYS-594, DEACETYLATION BY SIRT2, AND
RP   UBIQUITINATION BY UBR5.
RX   PubMed=21726808; DOI=10.1016/j.molcel.2011.04.028;
RA   Jiang W., Wang S., Xiao M., Lin Y., Zhou L., Lei Q., Xiong Y.,
RA   Guan K.L., Zhao S.;
RT   "Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation
RT   via recruiting the UBR5 ubiquitin ligase.";
RL   Mol. Cell 43:33-44(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) IN COMPLEX WITH GTP ANALOG; PEP
RP   AND MANGANESE, GTP-BINDING SITE, COFACTOR, SUBUNIT, AND ACTIVE SITE.
RX   PubMed=11851336; DOI=10.1006/jmbi.2001.5364;
RA   Dunten P., Belunis C., Crowther R., Hollfelder K., Kammlott U.,
RA   Levin W., Michel H., Ramsey G.B., Swain A., Weber D., Wertheimer S.J.;
RT   "Crystal structure of human cytosolic phosphoenolpyruvate
RT   carboxykinase reveals a new GTP-binding site.";
RL   J. Mol. Biol. 316:257-264(2002).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) IN COMPLEX WITH MANGANESE; GTP
RP   ANALOG AND PEP, AND COFACTOR.
RX   PubMed=14552798; DOI=10.1016/S0960-894X(03)00723-6;
RA   Foley L.H., Wang P., Dunten P., Ramsey G., Gubler M.L.,
RA   Wertheimer S.J.;
RT   "X-ray structures of two xanthine inhibitors bound to PEPCK and N-3
RT   modifications of substituted 1,8-dibenzylxanthines.";
RL   Bioorg. Med. Chem. Lett. 13:3871-3874(2003).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) IN COMPLEX WITH MANGANESE; GTP
RP   ANALOG AND PEP, COFACTOR, AND SUBUNIT.
RX   PubMed=17532214; DOI=10.1016/j.bmcl.2007.05.013;
RA   Pietranico S.L., Foley L.H., Huby N., Yun W., Dunten P., Vermeulen J.,
RA   Wang P., Toth K., Ramsey G., Gubler M.L., Wertheimer S.J.;
RT   "C-8 Modifications of 3-alkyl-1,8-dibenzylxanthines as inhibitors of
RT   human cytosolic phosphoenolpyruvate carboxykinase.";
RL   Bioorg. Med. Chem. Lett. 17:3835-3839(2007).
CC   -!- FUNCTION: Catalyzes the conversion of oxaloacetate (OAA) to
CC       phosphoenolpyruvate (PEP), the rate-limiting step in the metabolic
CC       pathway that produces glucose from lactate and other precursors
CC       derived from the citric acid cycle.
CC   -!- CATALYTIC ACTIVITY: GTP + oxaloacetate = GDP + phosphoenolpyruvate
CC       + CO(2).
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:11851336,
CC         ECO:0000269|PubMed:14552798, ECO:0000269|PubMed:17532214};
CC       Note=Binds 1 Mn(2+) ion per subunit. {ECO:0000269|PubMed:11851336,
CC       ECO:0000269|PubMed:14552798, ECO:0000269|PubMed:17532214};
CC   -!- ENZYME REGULATION: Enzyme activity is enhanced by acetylation.
CC       {ECO:0000269|PubMed:20167786}.
CC   -!- PATHWAY: Carbohydrate biosynthesis; gluconeogenesis.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:11851336,
CC       ECO:0000269|PubMed:17532214}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P35558-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P35558-2; Sequence=VSP_057073, VSP_057074;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Major sites of expression are liver, kidney
CC       and adipocytes.
CC   -!- INDUCTION: Regulated by cAMP and insulin.
CC       {ECO:0000269|PubMed:1656199}.
CC   -!- PTM: Lysine acetylation by p300/EP300 is increased on high glucose
CC       conditions and promotes ubiquitination by UBR5, acetylation is
CC       enhanced in the presence of BAG6. Deacetylated by SIRT2.
CC       {ECO:0000269|PubMed:20167786, ECO:0000269|PubMed:21726808}.
CC   -!- PTM: Ubiquitination by UBR5 leads to proteasomal degradation.
CC       {ECO:0000269|PubMed:21726808}.
CC   -!- DISEASE: Cytosolic phosphoenolpyruvate carboxykinase deficiency
CC       (C-PEPCKD) [MIM:261680]: Metabolic disorder resulting from
CC       impaired gluconeogenesis. It is a rare disease with less than 10
CC       cases reported in the literature. Clinical characteristics include
CC       hypotonia, hepatomegaly, failure to thrive, lactic acidosis and
CC       hypoglycemia. Autopsy reveals fatty infiltration of both the liver
CC       and kidneys. The disorder is transmitted as an autosomal recessive
CC       trait. Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- MISCELLANEOUS: In eukaryotes there are two isozymes: a cytoplasmic
CC       one and a mitochondrial one.
CC   -!- SIMILARITY: Belongs to the phosphoenolpyruvate carboxykinase [GTP]
CC       family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/pck1/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L05144; AAA60084.1; -; mRNA.
DR   EMBL; L12760; AAA02558.1; -; Genomic_DNA.
DR   EMBL; AY794987; AAV50001.1; -; Genomic_DNA.
DR   EMBL; AK290802; BAF83491.1; -; mRNA.
DR   EMBL; AK300072; BAG61876.1; -; mRNA.
DR   EMBL; AL035541; CAB55863.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75514.1; -; Genomic_DNA.
DR   EMBL; BC023978; AAH23978.1; -; mRNA.
DR   EMBL; U31519; AAA91026.1; -; Genomic_DNA.
DR   CCDS; CCDS13460.1; -. [P35558-1]
DR   PIR; A45746; A45746.
DR   RefSeq; NP_002582.3; NM_002591.3. [P35558-1]
DR   UniGene; Hs.1872; -.
DR   PDB; 1KHB; X-ray; 1.85 A; A=1-622.
DR   PDB; 1KHE; X-ray; 2.40 A; A=1-622.
DR   PDB; 1KHF; X-ray; 2.02 A; A=1-622.
DR   PDB; 1KHG; X-ray; 2.34 A; A=1-622.
DR   PDB; 1M51; X-ray; 2.25 A; A=1-622.
DR   PDB; 1NHX; X-ray; 2.10 A; A=1-622.
DR   PDB; 2GMV; X-ray; 2.30 A; A/B=1-622.
DR   PDBsum; 1KHB; -.
DR   PDBsum; 1KHE; -.
DR   PDBsum; 1KHF; -.
DR   PDBsum; 1KHG; -.
DR   PDBsum; 1M51; -.
DR   PDBsum; 1NHX; -.
DR   PDBsum; 2GMV; -.
DR   ProteinModelPortal; P35558; -.
DR   SMR; P35558; -.
DR   BioGrid; 111136; 76.
DR   IntAct; P35558; 2.
DR   MINT; MINT-3013923; -.
DR   STRING; 9606.ENSP00000319814; -.
DR   BindingDB; P35558; -.
DR   ChEMBL; CHEMBL2911; -.
DR   DrugBank; DB02008; 1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine.
DR   DrugBank; DB03267; 1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine.
DR   DrugBank; DB01819; Phosphoenolpyruvate.
DR   DrugBank; DB03725; Phosphomethylphosphonic Acid-Guanylate Ester.
DR   iPTMnet; P35558; -.
DR   PhosphoSitePlus; P35558; -.
DR   BioMuta; PCK1; -.
DR   DMDM; 93138710; -.
DR   EPD; P35558; -.
DR   MaxQB; P35558; -.
DR   PaxDb; P35558; -.
DR   PeptideAtlas; P35558; -.
DR   PRIDE; P35558; -.
DR   DNASU; 5105; -.
DR   Ensembl; ENST00000319441; ENSP00000319814; ENSG00000124253. [P35558-1]
DR   GeneID; 5105; -.
DR   KEGG; hsa:5105; -.
DR   UCSC; uc002xyn.5; human. [P35558-1]
DR   CTD; 5105; -.
DR   DisGeNET; 5105; -.
DR   GeneCards; PCK1; -.
DR   H-InvDB; HIX0015941; -.
DR   HGNC; HGNC:8724; PCK1.
DR   HPA; CAB017027; -.
DR   HPA; HPA006277; -.
DR   HPA; HPA006507; -.
DR   MalaCards; PCK1; -.
DR   MIM; 261680; phenotype.
DR   MIM; 614168; gene.
DR   neXtProt; NX_P35558; -.
DR   OpenTargets; ENSG00000124253; -.
DR   Orphanet; 79316; Phosphoenolpyruvate carboxykinase 1 deficiency.
DR   PharmGKB; PA33069; -.
DR   eggNOG; KOG3749; Eukaryota.
DR   eggNOG; COG1274; LUCA.
DR   GeneTree; ENSGT00390000001912; -.
DR   HOGENOM; HOG000191700; -.
DR   HOVERGEN; HBG053651; -.
DR   InParanoid; P35558; -.
DR   KO; K01596; -.
DR   OMA; WLSMAQH; -.
DR   OrthoDB; EOG091G02YK; -.
DR   PhylomeDB; P35558; -.
DR   TreeFam; TF314402; -.
DR   BioCyc; MetaCyc:HS04751-MONOMER; -.
DR   BRENDA; 4.1.1.32; 2681.
DR   Reactome; R-HSA-2161541; Abacavir metabolism.
DR   Reactome; R-HSA-381340; Transcriptional regulation of white adipocyte differentiation.
DR   Reactome; R-HSA-70263; Gluconeogenesis.
DR   SABIO-RK; P35558; -.
DR   SIGNOR; P35558; -.
DR   UniPathway; UPA00138; -.
DR   ChiTaRS; PCK1; human.
DR   EvolutionaryTrace; P35558; -.
DR   GeneWiki; PCK1; -.
DR   GenomeRNAi; 5105; -.
DR   PRO; PR:P35558; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000124253; -.
DR   CleanEx; HS_PCK1; -.
DR   Genevisible; P35558; HS.
DR   GO; GO:0005737; C:cytoplasm; ISS:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0031406; F:carboxylic acid binding; IDA:BHF-UCL.
DR   GO; GO:0019003; F:GDP binding; IEA:Ensembl.
DR   GO; GO:0005525; F:GTP binding; IDA:BHF-UCL.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:BHF-UCL.
DR   GO; GO:0030145; F:manganese ion binding; IDA:BHF-UCL.
DR   GO; GO:0004613; F:phosphoenolpyruvate carboxykinase (GTP) activity; ISS:BHF-UCL.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0071320; P:cellular response to cAMP; IEA:Ensembl.
DR   GO; GO:0071332; P:cellular response to fructose stimulus; IEA:Ensembl.
DR   GO; GO:0071377; P:cellular response to glucagon stimulus; IEA:Ensembl.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEA:Ensembl.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEA:Ensembl.
DR   GO; GO:0051365; P:cellular response to potassium ion starvation; IEA:Ensembl.
DR   GO; GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEA:Ensembl.
DR   GO; GO:0006094; P:gluconeogenesis; ISS:BHF-UCL.
DR   GO; GO:0042593; P:glucose homeostasis; ISS:BHF-UCL.
DR   GO; GO:0006006; P:glucose metabolic process; IMP:BHF-UCL.
DR   GO; GO:0046327; P:glycerol biosynthetic process from pyruvate; ISS:BHF-UCL.
DR   GO; GO:0006475; P:internal protein amino acid acetylation; IDA:UniProtKB.
DR   GO; GO:0006107; P:oxaloacetate metabolic process; IEA:Ensembl.
DR   GO; GO:0061402; P:positive regulation of transcription from RNA polymerase II promoter in response to acidic pH; IEA:Ensembl.
DR   GO; GO:0014823; P:response to activity; IEA:Ensembl.
DR   GO; GO:0032868; P:response to insulin; IDA:BHF-UCL.
DR   GO; GO:0070741; P:response to interleukin-6; IEA:Ensembl.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:1904640; P:response to methionine; IEA:Ensembl.
DR   Gene3D; 3.40.449.10; -; 1.
DR   Gene3D; 3.90.228.20; -; 2.
DR   HAMAP; MF_00452; PEPCK_GTP; 1.
DR   InterPro; IPR018091; PEP_carboxykin_GTP_CS.
DR   InterPro; IPR013035; PEP_carboxykinase_C.
DR   InterPro; IPR008209; PEP_carboxykinase_GTP.
DR   InterPro; IPR008210; PEP_carboxykinase_N.
DR   PANTHER; PTHR11561; PTHR11561; 1.
DR   Pfam; PF00821; PEPCK; 1.
DR   PIRSF; PIRSF001348; PEP_carboxykinase_GTP; 1.
DR   SUPFAM; SSF68923; SSF68923; 1.
DR   PROSITE; PS00505; PEPCK_GTP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Decarboxylase; Gluconeogenesis; GTP-binding; Lyase;
KW   Manganese; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Ubl conjugation.
FT   CHAIN         1    622       Phosphoenolpyruvate carboxykinase,
FT                                cytosolic [GTP].
FT                                /FTId=PRO_0000103627.
FT   NP_BIND     287    292       GTP. {ECO:0000269|PubMed:11851336}.
FT   NP_BIND     530    533       GTP. {ECO:0000269|PubMed:11851336,
FT                                ECO:0000269|PubMed:14552798,
FT                                ECO:0000269|PubMed:17532214}.
FT   REGION      235    237       Substrate binding.
FT                                {ECO:0000269|PubMed:11851336,
FT                                ECO:0000269|PubMed:14552798,
FT                                ECO:0000269|PubMed:17532214}.
FT   REGION      403    405       Substrate binding.
FT                                {ECO:0000269|PubMed:11851336,
FT                                ECO:0000269|PubMed:14552798,
FT                                ECO:0000269|PubMed:17532214}.
FT   ACT_SITE    288    288       {ECO:0000269|PubMed:11851336}.
FT   METAL       244    244       Manganese. {ECO:0000269|PubMed:11851336,
FT                                ECO:0000269|PubMed:14552798,
FT                                ECO:0000269|PubMed:17532214}.
FT   METAL       264    264       Manganese; via tele nitrogen.
FT                                {ECO:0000269|PubMed:11851336,
FT                                ECO:0000269|PubMed:14552798,
FT                                ECO:0000269|PubMed:17532214}.
FT   METAL       311    311       Manganese. {ECO:0000269|PubMed:11851336,
FT                                ECO:0000269|PubMed:14552798,
FT                                ECO:0000269|PubMed:17532214}.
FT   BINDING      87     87       Substrate. {ECO:0000269|PubMed:11851336,
FT                                ECO:0000269|PubMed:14552798,
FT                                ECO:0000269|PubMed:17532214}.
FT   BINDING     286    286       Substrate.
FT                                {ECO:0000250|UniProtKB:P07379}.
FT   BINDING     405    405       GTP. {ECO:0000269|PubMed:11851336}.
FT   BINDING     436    436       GTP. {ECO:0000269|PubMed:11851336}.
FT   MOD_RES      19     19       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES      70     70       N6-acetyllysine; by p300/EP300.
FT                                {ECO:0000269|PubMed:20167786,
FT                                ECO:0000269|PubMed:21726808}.
FT   MOD_RES      71     71       N6-acetyllysine; by p300/EP300.
FT                                {ECO:0000269|PubMed:20167786,
FT                                ECO:0000269|PubMed:21726808}.
FT   MOD_RES     118    118       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z2V4}.
FT   MOD_RES     178    178       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q16822}.
FT   MOD_RES     286    286       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q16822}.
FT   MOD_RES     594    594       N6-acetyllysine; by p300/EP300.
FT                                {ECO:0000269|PubMed:20167786,
FT                                ECO:0000269|PubMed:21726808}.
FT   VAR_SEQ       1      3       MPP -> MTT (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057073.
FT   VAR_SEQ       4    320       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057074.
FT   VARIANT      55     55       R -> Q (in dbSNP:rs28383585).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_021072.
FT   VARIANT      60     60       M -> T (in dbSNP:rs28383586).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_021073.
FT   VARIANT     138    138       T -> I (in dbSNP:rs28359542).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_021074.
FT   VARIANT     184    184       V -> L (in dbSNP:rs707555).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:8325643,
FT                                ECO:0000269|PubMed:8490617,
FT                                ECO:0000269|Ref.6}.
FT                                /FTId=VAR_021075.
FT   VARIANT     267    267       I -> V (in dbSNP:rs8192708).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_015575.
FT   VARIANT     276    276       E -> K (in dbSNP:rs11552145).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_021076.
FT   VARIANT     368    368       V -> I (in dbSNP:rs1804160).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_021077.
FT   VARIANT     427    427       P -> S (in dbSNP:rs28359550).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_021078.
FT   VARIANT     586    586       E -> D (in dbSNP:rs1042529).
FT                                {ECO:0000269|PubMed:8490617}.
FT                                /FTId=VAR_042444.
FT   MUTAGEN      70     70       K->R: Abolishes acetylation and increases
FT                                protein stability; when associated with
FT                                R-71 and R-594.
FT                                {ECO:0000269|PubMed:20167786}.
FT   MUTAGEN      71     71       K->R: Abolishes acetylation and increases
FT                                protein stability; when associated with
FT                                R-70 and R-594.
FT                                {ECO:0000269|PubMed:20167786}.
FT   MUTAGEN     594    594       K->R: Abolishes acetylation and increases
FT                                protein stability; when associated with
FT                                R-70 and R-71.
FT                                {ECO:0000269|PubMed:20167786}.
FT   CONFLICT    250    250       M -> N (in Ref. 2; AAA02558).
FT                                {ECO:0000305}.
FT   CONFLICT    256    256       K -> E (in Ref. 1; AAA60084).
FT                                {ECO:0000305}.
FT   CONFLICT    291    291       T -> S (in Ref. 2; AAA02558).
FT                                {ECO:0000305}.
FT   CONFLICT    551    552       KL -> NV (in Ref. 1; AAA60084).
FT                                {ECO:0000305}.
FT   CONFLICT    597    597       E -> V (in Ref. 1; AAA60084).
FT                                {ECO:0000305}.
FT   HELIX        11     14       {ECO:0000244|PDB:1KHB}.
FT   STRAND       15     18       {ECO:0000244|PDB:1KHB}.
FT   HELIX        20     22       {ECO:0000244|PDB:1KHB}.
FT   HELIX        25     38       {ECO:0000244|PDB:1KHB}.
FT   STRAND       41     45       {ECO:0000244|PDB:1KHB}.
FT   HELIX        50     62       {ECO:0000244|PDB:1KHB}.
FT   STRAND       65     68       {ECO:0000244|PDB:1KHF}.
FT   STRAND       72     74       {ECO:0000244|PDB:1KHB}.
FT   STRAND       76     78       {ECO:0000244|PDB:1KHB}.
FT   STRAND       84     86       {ECO:0000244|PDB:1KHB}.
FT   HELIX        89     91       {ECO:0000244|PDB:1KHB}.
FT   STRAND       92     95       {ECO:0000244|PDB:1KHB}.
FT   HELIX        99    102       {ECO:0000244|PDB:1KHB}.
FT   STRAND      107    109       {ECO:0000244|PDB:1KHB}.
FT   HELIX       119    129       {ECO:0000244|PDB:1KHB}.
FT   TURN        131    136       {ECO:0000244|PDB:1KHB}.
FT   STRAND      137    150       {ECO:0000244|PDB:1KHB}.
FT   STRAND      155    162       {ECO:0000244|PDB:1KHB}.
FT   HELIX       164    173       {ECO:0000244|PDB:1KHB}.
FT   STRAND      174    177       {ECO:0000244|PDB:1KHB}.
FT   HELIX       178    184       {ECO:0000244|PDB:1KHB}.
FT   STRAND      190    195       {ECO:0000244|PDB:1KHB}.
FT   HELIX       214    216       {ECO:0000244|PDB:1KHB}.
FT   STRAND      218    222       {ECO:0000244|PDB:1KHB}.
FT   HELIX       223    225       {ECO:0000244|PDB:1KHB}.
FT   STRAND      227    232       {ECO:0000244|PDB:1KHB}.
FT   HELIX       236    239       {ECO:0000244|PDB:1KHB}.
FT   HELIX       242    248       {ECO:0000244|PDB:1KHB}.
FT   HELIX       249    258       {ECO:0000244|PDB:1KHB}.
FT   STRAND      261    264       {ECO:0000244|PDB:1KHB}.
FT   STRAND      266    271       {ECO:0000244|PDB:1KHB}.
FT   STRAND      277    283       {ECO:0000244|PDB:1KHB}.
FT   STRAND      286    288       {ECO:0000244|PDB:2GMV}.
FT   HELIX       290    294       {ECO:0000244|PDB:1KHB}.
FT   STRAND      304    311       {ECO:0000244|PDB:1KHB}.
FT   STRAND      313    317       {ECO:0000244|PDB:1KHB}.
FT   STRAND      321    326       {ECO:0000244|PDB:1KHB}.
FT   STRAND      330    335       {ECO:0000244|PDB:1KHB}.
FT   TURN        341    343       {ECO:0000244|PDB:1KHB}.
FT   HELIX       345    350       {ECO:0000244|PDB:1KHB}.
FT   STRAND      356    359       {ECO:0000244|PDB:1KHB}.
FT   STRAND      361    363       {ECO:0000244|PDB:1KHB}.
FT   STRAND      388    391       {ECO:0000244|PDB:1KHB}.
FT   STRAND      395    397       {ECO:0000244|PDB:1KHB}.
FT   STRAND      405    409       {ECO:0000244|PDB:1KHB}.
FT   HELIX       410    412       {ECO:0000244|PDB:1KHB}.
FT   TURN        418    421       {ECO:0000244|PDB:1KHB}.
FT   STRAND      426    434       {ECO:0000244|PDB:1KHB}.
FT   STRAND      438    440       {ECO:0000244|PDB:1KHB}.
FT   STRAND      443    446       {ECO:0000244|PDB:1KHB}.
FT   HELIX       450    458       {ECO:0000244|PDB:1KHB}.
FT   STRAND      461    463       {ECO:0000244|PDB:1KHB}.
FT   STRAND      475    477       {ECO:0000244|PDB:1KHB}.
FT   HELIX       479    481       {ECO:0000244|PDB:1KHB}.
FT   TURN        483    485       {ECO:0000244|PDB:1KHB}.
FT   HELIX       490    499       {ECO:0000244|PDB:1KHB}.
FT   HELIX       500    502       {ECO:0000244|PDB:1KHB}.
FT   STRAND      510    514       {ECO:0000244|PDB:1KHB}.
FT   STRAND      525    527       {ECO:0000244|PDB:1KHB}.
FT   HELIX       530    533       {ECO:0000244|PDB:1KHB}.
FT   HELIX       534    544       {ECO:0000244|PDB:1KHB}.
FT   STRAND      550    553       {ECO:0000244|PDB:1KHB}.
FT   STRAND      556    559       {ECO:0000244|PDB:1KHB}.
FT   TURN        561    563       {ECO:0000244|PDB:1KHF}.
FT   HELIX       574    577       {ECO:0000244|PDB:1KHB}.
FT   HELIX       582    600       {ECO:0000244|PDB:1KHB}.
FT   HELIX       601    603       {ECO:0000244|PDB:1KHB}.
FT   HELIX       606    620       {ECO:0000244|PDB:1KHB}.
SQ   SEQUENCE   622 AA;  69195 MW;  78D309E0845CC181 CRC64;
     MPPQLQNGLN LSAKVVQGSL DSLPQAVREF LENNAELCQP DHIHICDGSE EENGRLLGQM
     EEEGILRRLK KYDNCWLALT DPRDVARIES KTVIVTQEQR DTVPIPKTGL SQLGRWMSEE
     DFEKAFNARF PGCMKGRTMY VIPFSMGPLG SPLSKIGIEL TDSPYVVASM RIMTRMGTPV
     LEAVGDGEFV KCLHSVGCPL PLQKPLVNNW PCNPELTLIA HLPDRREIIS FGSGYGGNSL
     LGKKCFALRM ASRLAKEEGW LAEHMLILGI TNPEGEKKYL AAAFPSACGK TNLAMMNPSL
     PGWKVECVGD DIAWMKFDAQ GHLRAINPEN GFFGVAPGTS VKTNPNAIKT IQKNTIFTNV
     AETSDGGVYW EGIDEPLASG VTITSWKNKE WSSEDGEPCA HPNSRFCTPA SQCPIIDAAW
     ESPEGVPIEG IIFGGRRPAG VPLVYEALSW QHGVFVGAAM RSEATAAAEH KGKIIMHDPF
     AMRPFFGYNF GKYLAHWLSM AQHPAAKLPK IFHVNWFRKD KEGKFLWPGF GENSRVLEWM
     FNRIDGKAST KLTPIGYIPK EDALNLKGLG HINMMELFSI SKEFWEKEVE DIEKYLEDQV
     NADLPCEIER EILALKQRIS QM
//
